11/12/2024
9:40 AM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
5:43 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
7:03 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
3:21 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:48 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/11/2024
3:54 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
3:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:20 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:45 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:50 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
5:34 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:41 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:37 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:39 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
3:53 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
4:44 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:39 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:14 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:33 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:31 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
5:15 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
4:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:33 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
3:50 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
5:51 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:38 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:43 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:14 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:10 AM | Mineralys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
3:24 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
04/11/2024
11:15 PM | Mineralys Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:35 PM | Mineralys Therapeutics (Filer)
| Form 424B5 | |
04/09/2024
6:15 AM | Mineralys Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
6:18 AM | Mineralys Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024
6:21 AM | Mineralys Therapeutics (Filer)
| Form ARS | |
04/04/2024
7:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:44 PM | Mineralys Therapeutics (Filer)
| Form S-3/A | |
03/21/2024
6:43 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:30 AM | Mineralys Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/21/2024
6:14 AM | Mineralys Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
4:35 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:20 PM | Mineralys Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024
8:06 PM | Mineralys Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:07 PM | AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:49 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:04 AM | ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
| Form SC 13G | |
02/08/2024
3:41 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:01 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
